[1] YU BL, LI YK, The adverse effects of bisphosphonates application[J].Chinese Journal of Osteoporosis(中国骨质疏松杂志), 2011, 17(1): 80-85. [2] ZHOU JW, MA X, ZHAI SD.Evaluation of comparative effectiveness and safety of bisphosphonates[J]. The Chinese Journal of Clinical Pharmacology(中国临床药理学杂志), 2015, 31(12): 1197-1201. [3] HUANG C, WANG SY, WENG XS.Progress in clinical application of bisphosphonates[J]. Journal of Practical Orthopaedics(实用骨科杂志), 2016, 22(1): 39-42. [4] ZHOU R, YUAN Z, LIU J, et al.A randomized double-blind placebo-control clinical study of risedronate sodium in prevention or treatment for postmenopausal osteoporosis[J]. Chinese Journal of Osteoporosis(中国骨质疏松杂志), 2010, 16(3): 173-176. [5] YANG X, WU YY, ZHANG SF, et al.Randomized, double-blind, multicenter comparative clinical trial of risedronate on bone mineral density in Chinese postmenopausal women[J]. The Chinese Journal of Clinical Pharmacology(中国临床药理学杂志), 2008, 24(3): 199-203. [6] XIAO Y, LIU P, JIANG LF.A case of drug-induced shock caused by risedronate sodium[J]. Herald of Medicine(医药导报), 2015, 34(z1): 189. [7] HU XL, LIU R, WANG YU.et al.Exfoliative dermatitis caused by risedronate sodium[J]. Adverse Drug Reactions Journal(药物不良反应杂志), 2012, 14(5): 304-305. [8] BIANCHI L, HANSEL K, ROMITA P, et al.Erythema multiforme-like eruption induced by risedronate.[J]. Contact Dermatitis, 2017, 77(5): 348-349. [9] YOUNG JK, SANG WK, JAE HL, et al.Marked elevation of procalc-itonin level can lead to a misdiagnosis of anaphylactic shock as septic shock[J]. International Journal of Infectious Diseases, 2015, 37: 93-94. [10] BELHADJALI H, SLIM R, AOUAM K, et al.Cutaneous vasculitis induced by risedronate[J]. Allergy, 2008, 63(10): 1405. [11] WANG ZJ, ZHAO WH, XIAN RL, et al.A case of anaphylactic shock caused by ibuprofen[J]. People's Military Surgeon(人民军医), 2014, 57(9): 1014. [12] ZHOU GM.A case of anaphylactic shock caused by ibuprofen sustained-release capsules[J]. Journal of Chinese Physician(中国医师杂志), 2015, 17(S1): 210-210. [13] PALM NW, ROSENSTEIN RK, MEDZHITOV R.Allergic host defences[J]. Nature, 2012, 484(7395): 465-472. [14] CHEN M, LI W, WANG X, et al.Progress in research of the mechanism and preclinical evaluation of drug pseudoallergy[J].Chinese Journal of New Drugs(中国新药杂志), 2017, 26(1): 51-59. [15] NISHIKAWA H, KITANI S.Gangliosides inhibit bee venommelittin cytotoxicity but not phospholipase A2-induceddegranulation in mast cells[J]. Toxicol Appl Pharmacol, 2011, 252(3): 228-236. [16] WANG L,GONG GM, SU H.Research on mechanisms and evaluation models of traditional Chinese medicine-induced pseudo-allergy[J]. Drug Evaluation Research(药物评价研究), 2019, 42(12): 2471-2477. [17] GANG HL, LIU Y, XIE SX, et al.Mechanism and evaluation methods of Chinese medicine injection induced allergic hypersensitivity reactions and pseudoallergic reactions[J]. Chinese Journal of Integrated Traditional and Western Medicine(中国中西医结合杂志), 2018, 38(4): 508-512. [18] YANG YF, XIE JJ, CHEN M, et al.Research progress on allergic reaction mechanism of Chinese medicine injection[J]. Chinese Traditional Patent Medicine(中成药), 2019, 41(8): 1935-1940. [19] YANG L, LIU GH.Pathogenesis, in vivo and in vitro test of drug allergy[J]. Chinese Journal of Allergy and Clinical Immunology(中华临床免疫和变态反应杂志), 2012, 6(2): 152-157. [20] TANG ZF, MEI QX, YANG GY, et al.Discussion on main types of adverse drug reactions and treatment methods of traditional chinese medicine injections[J]. Evaluation and Analysis of Drug-Use in Hospitals of China(中国医院用药评价与分析), 2019, 19(8): 1013-1016, 1020. [21] LI XT, ZHAI SD, WANG Q, et al.Recommendations in guideline for emergency management of anaphylaxis[J]. Adverse Drug Reactions Journal(药物不良反应杂志), 2019(2): 85-91. [22] MURARO A, ROBERTS G, WORM M, et al.Anaphylaxis: guidelines from the european academy of allergy and clinical immunology[J]. Allergy, 2014, 69(8): 1206-1245. [23] PAOLA LM, ALESSANDRO A, ANNA D, et al.Challenge test to bisphosphonates in patients with hypersensitivity reactions to drugs[J]. Allergologia et Immunopathologia, 2015, 43(2): 1-4. |